EDGAR Filing Documents for 0001485003-18-000017

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001485003-18-000017

Filing Date

2018-03-19

Accepted

2018-03-16 18:43:11

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	ebio-formsx3universalshelf.htm	S-3	485608
2	EXHIBIT 5.1	ebio-exhibit51opinion2018s.htm	EX-5.1	33978
3	EXHIBIT 23.1	exhibit231eyconsent.htm	EX-23.1	2631
4	EXHIBIT 23.2	pwcconsentlettermarch162018.htm	EX-23.2	4371
5		ebioexhibit51opinion2_image1.jpg	GRAPHIC	28105
6		ebioforms3universalsh_image1.jpg	GRAPHIC	3986
7		pwcconsentlettermarch_image1.gif	GRAPHIC	2883
8		pwcconsentlettermarch_image4.gif	GRAPHIC	2523
	Complete submission text file	0001485003-18-000017.txt		579651

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142

Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-223750 | Film No.: 18697030
SIC: 2834 Pharmaceutical Preparations